Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of a combination of polyethylene glycol and local anesthetic in non-narcotic analgesia

A technology of local anesthetic and polyethylene glycol, applied in the field of medicine, can solve the problems of short duration of non-narcotic analgesia, difficult to control, small window of high and low doses, etc.

Active Publication Date: 2021-07-23
JENKEM TECH CO LTD (LIAONING)
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, with the wide application of local anesthetics in clinical practice, their toxic and side effects are increasingly prominent, such as "Li Shuai, Li Wanli. Adverse reactions and prevention of local anesthetics. Naval Medical Journal, 2011 (4): 383-383. Local adverse reactions described in "such as local tissue reactions, nervous tissue reactions, cytotoxic reactions, systemic adverse reactions such as hypersensitivity reactions, allergic reactions (such as airway edema, bronchospasm, dyspnea, urticaria, etc.), central nervous Toxic reactions (such as perioral numbness, headache, dizziness, tinnitus, blurred vision, muscle twitching, unconsciousness, convulsions, etc.), cardiotoxic reactions (such as tachycardia, hypertension, arrhythmia, inhibition of myocardial systolic function, etc.), In particular, the prominent manifestation of severe toxicity of local anesthetics is convulsions. At this time, due to the uncoordinated and strong contraction of the airway and chest and abdominal muscles, the respiratory and cardiovascular systems are bound to be affected, which can be life-threatening.
The occurrence of the above-mentioned adverse reactions will additionally increase the pain and danger of the patient, and significantly reduce the patient's compliance
[0004] The inventors of the present invention have found through experiments and research that reducing the dosage of local anesthetics to an appropriate range can achieve non-narcotic analgesic effects, and can reduce some adverse reactions of local anesthetics, such as the motor nerve block effect on experimental animals. Decreased, but the maintenance time of non-narcotic analgesic effect is short. For example, the non-narcotic analgesic effect of a single administration of bupivacaine can only last for 1 hour at most. For analgesia, especially for chronic pain, frequent administration is required to achieve Long-acting analgesic effect is very inconvenient to use, which is not conducive to the compliance of patients who need analgesia, and the high and low dose window of local anesthetics that can play a non-narcotic analgesic effect is very small, which is difficult to control, so local anesthetics alone Medicine not suitable for non-narcotic analgesia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of a combination of polyethylene glycol and local anesthetic in non-narcotic analgesia
  • Application of a combination of polyethylene glycol and local anesthetic in non-narcotic analgesia
  • Application of a combination of polyethylene glycol and local anesthetic in non-narcotic analgesia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0143] Synthesis of embodiment 1 connecting chain (L1)

[0144]

[0145] Add 4-pentynoic acid (1.96g, 20mmol) and N,N-dicyclohexylcarbodiimide (DCC, 5.16g, 25mmol) into dichloromethane (50mL), cool in an ice-water bath, and then add p-hydroxyl Benzaldehyde (2.68g, 22mmol), the ice bath was removed after the addition, and reacted at room temperature overnight. After filtration, the filter cake was washed with ethyl acetate, and the filtrate was evaporated to dryness to obtain a crude product, which was purified by column chromatography to obtain 3.52 g of product 1a.

[0146] Compound 1a (3.23g, 16mmol) was added to anhydrous methanol (35mL), cooled to 0°C, then sodium borohydride (365mg, 9.6mmol) was added, reacted at the same temperature for 10min, and then quenched with 1M HCl, Methanol was spin-dried, ethyl acetate and saturated brine were added, the aqueous phase was extracted with ethyl acetate, the organic phases were combined, washed with saturated brine, dried, fil...

Embodiment 2

[0148] The synthesis of embodiment 2 lidocaine quaternary ammonium salts (Y1)

[0149]

[0150] Lidocaine (0.50 g, 2.13 mmol) and compound L1 (1.00 g, 3.19 mmol) were added into acetonitrile (20 mL), and reacted overnight at 50°C. TLC monitoring showed that the reaction of lidocaine was complete, and the reaction solution was concentrated to obtain a crude product. Purification by column chromatography yielded 1.19 g of product Y1. 1 H NMR: (CDCl 3 ): 1.59(m, 6H), 2.06(s, 2H), 2.31(s, 6H), 2.64(m, 2H), 2.87(m, 2H), 3.49(m, 2H), 3.71(m, 2H) , 4.89 (s, 2H), 4.93 (s, 2H), 7.06 (m, 3H), 7.28 (d, 2H), 7.62 (d, 2H), 9.79 (s, 1H).

Embodiment 3

[0151] Synthesis of Example 3 lidocaine conjugate 1 (mPEG-lidocaine, 20K)

[0152]

[0153] mPEG-N 3 (20K, 2.00g, 0.10mmol), compound Y1 (65.8mg, 0.12mmol), vitamin C (52.8mg, 0.30mmol) were added to N,N-dimethylformamide (20mL), stirred rapidly to dissolve , and then copper sulfate pentahydrate (30.0 mg, 0.12 mmol) in water (4.4 mL, 2.2 mL / g PEG) was added, reacted overnight at room temperature, and precipitated with isopropanol to obtain 1.90 g of product. 1 H NMR: (CDCl 3 ): 1.42(m, 6H), 2.19(s, 6H), 3.02(m, 4H), 3.23(m, 4H), 3.31(s, 3H), 3.50(m, 1800H), 3.80(m, 2H) , 4.20(m, 2H), 4.50(s, 2H), 4.82(s, 2H), 7.12(m, 3H), 7.30(d, 2H), 7.64(d, 2H), 7.91(s, 1H), 10.28(s, 1H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses the application of a combination of polyethylene glycol and local anesthetic in non-narcotic analgesia. In the present invention, the local anesthetic is made into a prodrug or a sustained-release preparation, wherein the high molecular polymer in the prodrug such as polyethylene glycol is covalently bonded with the local anesthetic, and the auxiliary material in the sustained-release preparation plays a sustained-release role Combined with local anesthetics in a non-covalent bond, after administration, there is no anesthesia and analgesic effect before the free local anesthetic is released, and the analgesic effect is released after the free local anesthetic is released, and the local anesthetic of the present invention The prodrug or sustained-release preparation of the drug releases the drug slowly, which can keep the drug concentration stable and lasting within the effective concentration range of non-narcotic analgesia, while significantly reducing the clinical adverse reactions of local anesthetics and reducing the number of administrations. , can achieve long-acting non-narcotic analgesic effect, enhance the effectiveness of the drug, and expand the clinical application range of local anesthetics.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to the application of a combination of polyethylene glycol and local anesthetic in non-narcotic analgesia, especially long-acting non-narcotic analgesia. Background technique [0002] Chronic pain, especially postoperative pain, is a common clinical symptom. The diseases involved include various clinical departments. While making patients feel painful, it will also produce a series of pathophysiological changes, such as affecting the body's autonomic nervous system, Accelerate heart rate, shortness of breath, and increase blood pressure; affect emotions, cause irritability, depression, and then affect the recovery of digestive system function and physical strength; affect endocrine and hormone levels, directly and indirectly disrupt the internal environment of the body. Therefore, reasonable analgesia can play the following roles: (1) reduce the pain and discomfort of patients, rel...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K47/60A61K45/00A61K31/167A61K31/445A61K31/4458A61K47/50A61P29/00
CPCA61K45/00A61K31/167A61K31/445A61K31/4458A61K47/60A61P23/02A61K45/06A61K9/127A61K9/107A61K9/0019A61K47/02A61K9/2059A61K9/2866A61K9/2018A61K9/2054A61K9/19A61K47/545
Inventor 冯泽旺汪进良熊艳丽石娟赵宣
Owner JENKEM TECH CO LTD (LIAONING)
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com